日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2.

抗体Fc受体结合和T细胞对同源和异源灭活疫苗或mRNA疫苗抗SARS-CoV-2免疫的反应

Cohen Carolyn A, Leung Nancy H L, Kaewpreedee Prathanporn, Lee Kelly W K, Jia Janice Zhirong, Cheung Alan W L, Cheng Samuel M S, Mori Masashi, Ip Dennis K M, Poon Leo L M, Peiris J S Malik, Cowling Benjamin J, Valkenburg Sophie A

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial

比较使用 CoronaVac 和 BNT162b2 (Cobovax) 进行同源和异源加强免疫的抗体和细胞介导免疫反应、反应原性和疗效:一项开放标签、随机试验

Leung, Nancy H L; Cheng, Samuel M S; Cohen, Carolyn A; Martín-Sánchez, Mario; Au, Niki Y M; Luk, Leo L H; Tsang, Leo C H; Kwan, Kelvin K H; Chaothai, Sara; Fung, Lison W C; Cheung, Alan W L; Chan, Karl C K; Li, John K C; Ng, Yvonne Y; Kaewpreedee, Prathanporn; Jia, Janice Z; Ip, Dennis K M; Poon, Leo L M; Leung, Gabriel M; Peiris, J S Malik; Valkenburg, Sophie A; Cowling, Benjamin J